Further emphasising the importance of the ECM, Marfan syndrome, defined by mutations in the ECM component fibrillin-1 (FBN1), presents with an increased risk of aortic aneurysm (Pereira et al., 1997; Dietz and Pyeritz, 1995). This evidence concerns the gene FBN1 and Marfan syndrome.